Randy is a nationally recognized leader in the commercialization and value communication of emerging healthcare technologies. As such, he has advised pre-Series A to multinational life sciences companies on product & process development, evidence generation, strategic partnerships, and business development. He collaborates widely with national healthcare systems, health insurance payers, regulators, and investors.
Randy specializes in products with relevance to precision medicine (molecular diagnostics, pharmacogenomics, and targeted therapies), digital health, software as a medical device (SaMD), and algorithmic (AI/ML) medicine. He holds a Master’s degree from Binghamton University, Ph.D. from the University of Kansas, and a Post Doctorate from the University of California – Irvine. Over the course of his career, Dr. David has led both large (100+ person) cross-matrixed teams working in government research and operations, as well as small expert divisions. He has held numerous board/advisory roles and multiple faculty appointments, publishing broadly, and frequently being invited to speak at national conferences.